SEC Hits Valeant With Multi-Pronged Probe
The SEC has also requested information regarding Valeant’s stock option grants going back to 2000, the company said. The specialty pharmaceutical business is now one of more than 100 companies being probed by the government for options backdating.
Valeant said it is cooperating with the investigations. It also said it is conducting an internal review...
To view the full article, register now.